| |
| |
|
| Insider
Information: |
Kakkis Emil D |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
603,534 |
|
|
Indirect Shares
|
2,268,639 |
|
|
| Direct
Value |
$27,122,647 |
|
|
|
Indirect Value
|
$95,205,536 |
|
|
| Total
Shares |
2,872,173 |
|
|
| Total
Value |
$122,328,183 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Chief Medical Officer |
2009-03-02 |
39,621 |
2009-03-02 |
4,654 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
563,913 |
2024-03-01 |
2,263,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-06-01 |
4 |
D |
$69.38 |
$92,553 |
D/D |
(1,334) |
611,041 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-10-14 |
4 |
D |
$92.69 |
$78,972 |
D/D |
(852) |
610,189 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2021-03-01 |
4 |
D |
$142.47 |
$2,328,245 |
D/D |
(16,342) |
596,052 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2021-05-06 |
4 |
D |
$115.71 |
$98,585 |
D/D |
(852) |
595,200 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2021-10-14 |
4 |
D |
$81.00 |
$69,093 |
D/D |
(853) |
594,347 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2022-03-01 |
4 |
D |
$67.37 |
$819,354 |
D/D |
(12,162) |
582,185 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2023-03-01 |
4 |
D |
$45.65 |
$736,791 |
D/D |
(16,140) |
599,176 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2024-03-01 |
4 |
D |
$53.69 |
$935,119 |
D/D |
(17,417) |
560,781 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2007-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
86,164 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2015-12-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
18,121 |
557,519 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-12-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
27,500 |
419,647 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
See RemarksOfficer |
• • • |
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,552,241 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2003-12-29 |
4 |
OE |
$7.00 |
$71,309 |
I/I |
10,187 |
21,297 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2006-01-04 |
4 |
OE |
$4.00 |
$200,000 |
D/D |
50,000 |
88,144 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-03-06 |
4 |
OE |
$4.00 |
$72,000 |
D/D |
18,000 |
104,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-01 |
4 |
OE |
$4.00 |
$72,000 |
D/D |
18,000 |
104,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-29 |
4 |
OE |
$4.00 |
$300,000 |
D/D |
75,000 |
161,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-05-01 |
4 |
OE |
$4.00 |
$72,000 |
D/D |
18,000 |
180,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-06-02 |
4 |
OE |
$4.00 |
$64,000 |
D/D |
16,000 |
178,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-09-02 |
4 |
OE |
$6.13 |
$36,780 |
D/D |
6,000 |
133,304 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-10-01 |
4 |
OE |
$6.13 |
$110,340 |
D/D |
18,000 |
133,304 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-11-03 |
4 |
OE |
$6.13 |
$98,080 |
D/D |
16,000 |
131,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-11-03 |
4 |
OE |
$18.11 |
$307,938 |
D/D |
17,000 |
114,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
CHIEF MEDICAL OFFICER |
• – – |
2008-12-01 |
4 |
OE |
$6.13 |
$104,210 |
D/D |
17,000 |
56,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical officer |
• – – |
2009-01-02 |
4 |
OE |
$6.13 |
$107,335 |
D/D |
17,000 |
56,621 |
0 |
- |
|
106 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
